<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04517929</url>
  </required_header>
  <id_info>
    <org_study_id>20-6.1T/49</org_study_id>
    <nct_id>NCT04517929</nct_id>
  </id_info>
  <brief_title>Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome</brief_title>
  <official_title>Effectiveness of Group Psychotherapy in Patients With Fibromyalgia Syndrome, Randomized Controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ege University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ege University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the study is that group therapy in fibromyalgia patients can provide&#xD;
      significant improvement in pain, fatigue, anxiety and depression levels and emotional&#xD;
      expressions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of our study; to determine the effectiveness of group psychotherapy in the&#xD;
      treatment of Fibromyalgia Syndrome.&#xD;
&#xD;
      Patients who received 9 weeks of group therapy and those who did not, at the beginning of&#xD;
      treatment, at the end of 9 weeks and 6 months after treatment will be evaluated using The&#xD;
      Short Form-36, Fibromyalgia Impact Questionnaire, Revised Fibromyalgia Impact Questionnaire,&#xD;
      Hospital Anxiety and Depression Scale, Fatigue Severity Scale, Beck Depression Inventory,&#xD;
      Beck Anxiety Inventory, Pain Beliefs Scale, Emotional Expression Questionnaire, Visual&#xD;
      Analogue Scale, Childhood Trauma Questionnaire, 2016 Fibromyalgia Diagnostic Criteria.&#xD;
&#xD;
      At the end of the study, individuals are expected to show less depressive symptoms and&#xD;
      anxiety symptoms compared to the beginning of the study, and it is thought that their&#xD;
      complaints about pain will decrease.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 20, 2020</start_date>
  <completion_date type="Anticipated">May 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Pain-Visual Analog Scale</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Chronic musculoskeletal pain in Fibromyalgia syndrome patients, in this scale minumum value is 0, maximum value is 10, higher scores means worse outcome.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Depression-Beck Depression Inventory</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Depression in Fibromyalgia patients</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in Anxiety-Beck Anxiety Inventory</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Anxiety in Fibromyalgia patients</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in The Short Form (36) Health Survey</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>The Short Form (36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Fibromyalgia Impact Questionaire</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Fibromyalgia Impact Questionaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Revised Fibromyalgia Impact Questionnaire</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Revised Fibromyalgia Impact Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Hospital Anxiety and Depression Scale</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Hospital Anxiety and Depression Scale, in this scale minumum value is 0, maximum value is 21, high scores mean worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in The Fatigue Severity Scale</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>The Fatigue Severity Scale, In this scale consisting of 9 items, each item is scored between 1 and 7 (1 = strongly disagree, 7 = totally agree) and the total score is calculated by taking the average of 9 items, high scores mean worse outcome.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pain beliefs questionnaire</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Pain beliefs questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Emotional Expression Questionnaire</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>Emotional Expression Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>CHILDHOOD TRAUMA QUESTIONNAIRE</measure>
    <time_frame>At the beginning of the study</time_frame>
    <description>CHILDHOOD TRAUMA QUESTIONNAIRE</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in 2016 Fibromyalgia Syndrome Criteria</measure>
    <time_frame>At the beginnning of the study ,through study completion-8th week, after study completion -6th month</time_frame>
    <description>2016 Fibromyalgia Syndrome Criteria&#xD;
2016 Fibromyalgia Diagnostic Criteria</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">16</enrollment>
  <condition>Fibromyalgia Syndrome</condition>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients in this group will receive recommendations regarding lifestyle change, exercise, and nutrition related to fibromyalgia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>intervention group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in this group will receive recommendations regarding lifestyle change, exercise, and nutrition related to fibromyalgia and group psychotherapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Group Psychotherapy</intervention_name>
    <description>9 week group psychotherapy, given by a psychologist trained in group psychotherapy.</description>
    <arm_group_label>intervention group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Fibromyalgia Syndrome diagnosed according to 2016 Fibromyalgia Syndrome diagnostic&#xD;
             criteria&#xD;
&#xD;
          -  Volunteers between the ages of 18-65&#xD;
&#xD;
          -  Literate volunteers&#xD;
&#xD;
          -  Volunteering to participate in group work&#xD;
&#xD;
          -  There is no obstacle to attend the sessions regularly every week&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Who cannot participate in 9-week group therapy&#xD;
&#xD;
          -  Under 18, over 65 years old&#xD;
&#xD;
          -  Confused enough to not be able to complete and understand the scales given cognitively&#xD;
&#xD;
          -  Having serious mental illness (eg Psychotic disorder, Mental Retardation etc.)&#xD;
&#xD;
          -  Illiterate individuals&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Simin HEPGULER</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ege University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Basak DURDU AKGUN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ege University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Meryem Burcu TURKOGLU</last_name>
    <phone>00905077974838</phone>
    <email>meryemburcu.turkoglu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ege University Faculty of Medicine</name>
      <address>
        <city>Izmır</city>
        <zip>35100</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Meryem Burcu Turkoglu, Resident</last_name>
      <phone>009005077974838</phone>
      <email>meryemburcu.turkoglu@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <reference>
    <citation>Clauw DJ, Arnold LM, McCarberg BH; FibroCollaborative. The science of fibromyalgia. Mayo Clin Proc. 2011 Sep;86(9):907-11. doi: 10.4065/mcp.2011.0206. Review.</citation>
    <PMID>21878603</PMID>
  </reference>
  <reference>
    <citation>Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi-Puttini P, Macfarlane GJ. The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheumatol. 2015 Feb;67(2):568-75. doi: 10.1002/art.38905.</citation>
    <PMID>25323744</PMID>
  </reference>
  <reference>
    <citation>Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L. An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord. 2007 Mar 9;8:27.</citation>
    <PMID>17349056</PMID>
  </reference>
  <reference>
    <citation>Arnold LM, Hudson JI, Keck PE, Auchenbach MB, Javaras KN, Hess EV. Comorbidity of fibromyalgia and psychiatric disorders. J Clin Psychiatry. 2006 Aug;67(8):1219-25.</citation>
    <PMID>16965199</PMID>
  </reference>
  <reference>
    <citation>BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71.</citation>
    <PMID>13688369</PMID>
  </reference>
  <reference>
    <citation>Hisli N. Beck Depresyon Ölçeği'nin bir Türk örnekleminde geçerlik ve güvenirliği. Psikoloji Dergisi 1988; 6:118-122.</citation>
  </reference>
  <reference>
    <citation>Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7.</citation>
    <PMID>3204199</PMID>
  </reference>
  <reference>
    <citation>Ulusoy M, Şahin NH, Erkmen H. Turkish version of the Beck Anxiety Inventory: Psychometric properties. J Cognit Psychother 1996; 12:163- 172</citation>
  </reference>
  <reference>
    <citation>Edwards LC, Pearce SA, Turner-Stokes L, Jones A. The Pain Beliefs Questionnaire: an investigation of beliefs in the causes and consequences of pain. Pain. 1992 Dec;51(3):267-272. doi: 10.1016/0304-3959(92)90209-T.</citation>
    <PMID>1491853</PMID>
  </reference>
  <reference>
    <citation>Bernstein DP, Fink L, Handelsman L, Foote J, Lovejoy M, Wenzel K, Sapareto E, Ruggiero J. Initial reliability and validity of a new retrospective measure of child abuse and neglect. Am J Psychiatry. 1994 Aug;151(8):1132-6.</citation>
    <PMID>8037246</PMID>
  </reference>
  <reference>
    <citation>Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, Stokes J, Handelsman L, Medrano M, Desmond D, Zule W. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl. 2003 Feb;27(2):169-90.</citation>
    <PMID>12615092</PMID>
  </reference>
  <reference>
    <citation>Kuzucu Y. , &quot;Duyguları İfade Etme Ölçeği'nin Uyarlanması: Geçerlik Ve Güvenirlik Çalışmaları&quot; Kastamonu Eğitim Dergisi, Cilt:19 No:3, 2011,779-792.</citation>
  </reference>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>July 27, 2020</study_first_submitted>
  <study_first_submitted_qc>August 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2020</study_first_posted>
  <last_update_submitted>November 19, 2020</last_update_submitted>
  <last_update_submitted_qc>November 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ege University</investigator_affiliation>
    <investigator_full_name>Meryem Burcu Turkoglu</investigator_full_name>
    <investigator_title>Principal invastigator</investigator_title>
  </responsible_party>
  <keyword>fibromyalgia</keyword>
  <keyword>group therapy</keyword>
  <keyword>group psychotherapy</keyword>
  <keyword>pain</keyword>
  <keyword>depression</keyword>
  <keyword>anxiety</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

